Dravya Discovery offers consultancy and CRO Services in Ophthalmology, Oncology and Neuroscience
ABOUT US
"The lab had no in-house capabilities for angiogenic or ophthalmic assays; therefore all work was outsourced. Very few CROs were offering good data, quality based assays, even fewer offered consultancy services."
- Dr. Vineeta Tripathi, CEO, CSO Dravya Discovery
Dravya Discovery was founded as the team identified an unmet market need in the area of ophthalmic preclinical research and target validation.
Our niche CRO offers expertise in cell, tissue and animal-based drug discovery and development assay.
WHAT YOU GET
Our disease-relevant, fit-for-purpose, clinically validated translational assays and target-to-assay consultancy help scientists in drug development and target validation who need quality data for lead selection.
Our high and medium throughput assays screen drug candidates in campaign sizes from 1 to >100 molecules.
Dravya's Mantra
GLP-consistent execution
IP consciousness
Effective communication
Passion for science
Dravya's experience.
Your scientific needs.
A Promising partnership.
Our analytic expertise and GLP compliant execution deliver pre-IND quality data. With in-house study design services, digital data analyses, and our teams’ vast experience in big pharma we are the right CRO to support your goal: Get your drug developed, fast.
How can we help you?
Indications we support
AMD
wet / dry
Diabetic
Retinopathy
Geographic
Atrophy
Retinopathy of Prematurity
Get in touch with us today
Simply drop us a note below
